SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Nankervis H.)
 

Sökning: WFRF:(Nankervis H.) > Evaluation of the m...

  • Gerbens, L. A AAcademic Medical Center of University of Amsterdam (AMC) (författare)

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema : A systematic review

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • 2016-07-13
  • Wiley,2017

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:1535e452-a62c-4e94-964f-34937f1f9f05
  • https://lup.lub.lu.se/record/1535e452-a62c-4e94-964f-34937f1f9f05URI
  • https://doi.org/10.1111/all.12959DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Background: Symptoms have been identified as a core outcome domain for atopic eczema (AE) trials. Various instruments exist to measure symptoms in AE, but they vary in quality and there is a lack of standardization between clinical trials. Our objective was to systematically evaluate the quality of the evidence on the measurement properties of AE symptom instruments, thereby informing consensus discussions within the Harmonising Outcome Measures for Eczema (HOME) initiative regarding the most appropriate instruments for the core outcome domain symptoms. Methods: Using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist and predefined criteria for good measurement properties on identified development and validation studies of AE symptom instruments, a best evidence synthesis was performed to draw an overall conclusion on quality of the instruments and to provide recommendations. Results: Eighteen instruments were identified and evaluated. When the quality and results of the studies were considered, only five of these instruments had sufficient validation data to consider them for the core outcome set for the core outcome domain symptoms. These were the paediatric Itch Severity Scale (ISS), Patient-Oriented Eczema Measure (POEM), Patient-Oriented SCOring Atopic Dermatitis (PO-SCORAD), Self-Administered Eczema Area and Severity Index (SA-EASI) and adapted SA-EASI. Conclusions: ISS (paediatric version), POEM, PO-SCORAD, SA-EASI and adapted SA-EASI are currently the most appropriate instruments and therefore have the potential to be recommended as core symptom instrument in future clinical trials. These findings will be utilized for the development of a core outcome set for AE.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Prinsen, C. A CAmsterdam UMC - Vrije Universiteit Amsterdam (författare)
  • Chalmers, J. R.University of Nottingham (författare)
  • Drucker, A. M.Brown University (författare)
  • von Kobyletzki, L. B.Lund University,Lunds universitet,Yrkes- och miljödermatologi,Forskargrupper vid Lunds universitet,Occupational and Environmental Dermatology,Lund University Research Groups(Swepub:lu)la7747vo (författare)
  • Limpens, J.Academic Medical Center of University of Amsterdam (AMC) (författare)
  • Nankervis, H.University of Nottingham (författare)
  • Svensson, ÅkeLund University,Lunds universitet,Yrkes- och miljödermatologi,Forskargrupper vid Lunds universitet,Occupational and Environmental Dermatology,Lund University Research Groups(Swepub:lu)derm-asv (författare)
  • Terwee, C. B.Amsterdam UMC - Vrije Universiteit Amsterdam (författare)
  • Zhang, J.Peking University (författare)
  • Apfelbacher, C. J.University of Regensburg (författare)
  • Spuls, P. I.Academic Medical Center of University of Amsterdam (AMC) (författare)
  • Academic Medical Center of University of Amsterdam (AMC)Amsterdam UMC - Vrije Universiteit Amsterdam (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Allergy: European Journal of Allergy and Clinical Immunology: Wiley72:1, s. 146-1630105-4538

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy